Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan

Background Since the launch of imatinib, chronic myeloid leukaemia has become a chronic condition requiring costly long-term treatment. Emerging evidence from several short-term studies has raised concerns on the detrimental clinical outcomes and waste of resources associated with poor adherence to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Teng-Chou, Chen, Li-Chia, Huang, Yaw-Bin, Chang, Chao-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890042/
https://www.ncbi.nlm.nih.gov/pubmed/24242992
http://dx.doi.org/10.1007/s11096-013-9876-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890042/
https://www.ncbi.nlm.nih.gov/pubmed/24242992
http://dx.doi.org/10.1007/s11096-013-9876-7

Ejemplares similares